October 16, 2015
FDA: Blood thinners can prevent strokes
Blood thinner (anticoagulant) can reduce the risk of a stroke by 50% to 60% for people who have atrial fibrillation.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
October 16, 2015
FDA approved Praxbind for patients taking Pradaxa
The U.S. Food and Drug Administration on Friday granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.
October 16, 2015
Onabotulinumtoxin A treatment decrease urinary incontinence in women
“These findings may help inform specialists treating patients with overactive bladder, that BOTOX is an effective and safe treatment option for patients not getting the relief from an anticholinergic.”
October 16, 2015
USA:Recall of lot # 45810 of Acetaminophen tablets
Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot # 45810 of Acetaminophen tablets, 500mg, uncoated compressed tablets to the consumer level.
October 13, 2015
Johnson & Johnson sales for third quarter 2015 decrease year to year
Johnson & Johnson has had sales of $17.1 billion for the third quarter of 2015, a decrease of 7.4% as compared to the third quarter of 2014.
October 13, 2015
FDA: Skipanon Brand Seafoods LLC Recalls all Seafood Canned Products
Skipanon Brand Seafoods LLC of Warrenton, Oregon is voluntarily recalling ALL LOTS, ALL SIZES of ALL Skipanon brand seafoods canned products because it has the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.
October 13, 2015
ene therapy staves off blindness from retinitis pigmentosa in canine model
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health.
October 12, 2015
TF Supplements recalls sexual enhancement Rhino 7 Platinum 3000 capsules
TF Supplements of Houston, TX, is voluntarily recalling RHINO 7 3000 capsules packaged in a bottle containing six capsules and Rhino 7 Platinum 3000 Capsules packaged in a single blister packs hang card count.
October 12, 2015
Eli Lilly: Evacetrapib Phase 3 trial terminated
Eli Lilly and Company and the ACCELERATE study’s academic leadership have accepted the recommendation of the independent data monitoring committee to terminate the Phase 3 trial of the investigational medicine evacetrapib, due to insufficient efficacy.
October 12, 2015
FDA: Opdivo approved for treating patients with advanced non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.